부가기능
Overhauling Teva: Conversations With Jeremy Levin And Michael Hayden: Teva CEO Jeremy Levin and CSO Michael Hayden discuss their plans to re-focus the company on innovative R&D and selective generics opportunities, which means an overhaul of the R&D organization and new priorities for business development
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.